New data bolsters Prescient Therapeutics' focus on next generation CAR-T cell therapy for cancers

Retrieved on: 2022-02-15 06:33:16

Tags for this article:

Click the tags to see associated articles and topics

New data bolsters Prescient Therapeutics' focus on next generation CAR-T cell therapy for cancers. View article details on hiswai:

Excerpt

New data published in the science journal Nature has supported clinical stage oncology company Prescient Therapeutics' (ASX: PTX) use of next ...

Article found on: smallcaps.com.au